Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Helicobacter pylori -

Helicobacter pylori

Nayoung Kim (Herausgeber)

Buch | Hardcover
556 Seiten
2016
Springer Verlag, Singapore
978-981-287-705-5 (ISBN)
CHF 329,50 inkl. MwSt
zur Neuauflage
  • Titel erscheint in neuer Auflage
  • Artikel merken
Zu diesem Artikel existiert eine Nachauflage
This book presents thecurrent state of knowledge regarding the ability of Helicobacter pylori to colonize the gastrointestinal tract, theglobal epidemiology of H. pylori-related gastroduodenal and other diseases, diagnosis andtreatment methods, guidelines for eradication, antibiotic resistance, thereinfection rate after H.
This book presents the
current state of knowledge regarding the ability of Helicobacter pylori to colonize the gastrointestinal tract, the
global epidemiology of H. pylori
infection, transmission routes, the pathophysiology of H. pylori-related gastroduodenal and other diseases, diagnosis and
treatment methods, guidelines for eradication, antibiotic resistance, the
reinfection rate after H. pylori eradication,
and animal models of H. pylori or
related Helicobacter infection. The
aim is to equip readers around the world with the understanding required in
order to implement effective methods of H.
pylori eradication and to enhance clinical outcomes for patients. The text
is clearly written and is complemented by many helpful illustrations. This book
will be a great asset in clinical practice for all practitioners who are
involved in caring for patients with H.
pylori-related diseases or have an interest in the subject. It will also be
a useful source of information for medical students and for intelligent laypeople
seeking information on H. pylori.

Nayoung Kim MD Ph.D., Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Republic of Korea

Part 1. Epidemiology-Prevalence and
Transmission routes of H. pylori.- Part 2. Pathophysiology.- 1) Colonization of
H. pylori in the stomach.- 2) Brief description of Pathophysiology.- 3) Immune
mechanism.- 4) Change of acid secretion, ghrelin and leptin by H. pylori.- 5) H.
pylori virulence factors.- A: toxin (CagA, VacA, DupA, OipA, IceA).- B: genetic
polymorphism of toxin and disease.- 6) Host factors: genetic polymorphism,
etc.- Part 3. Diagnosis.- 1) Serology.- 2) Histology.- 3) Culture.- 4) UBT.- 5)
Stool antigen.- 6) Specific conditions.- A: Children.- B: Bleeding.- Part
4. Symptom.- 1)Symptom of acute and chronic H. pylori infection.- Part 5.
Disease.- 1) Atrophic gastritis and Intestinal metaplasia.- 2) Functional dyspepsia.-
3) Peptic ulcer.- 4) MALToma.- 5) Gastric cancer.- A: Synopsis and Epidemiology
of gastric cancer.- B1: Pathogenesis: i.Genetic alternation (mutations in
tumor-related genes) induced by Activation-induced cytidine deaminase (AID).- B2:
Pathogenesis: ii. Epigenetic mechanisms: aberrant DNA methylation, microRNA.- B3:
Pathogenesis:iii. Macrophage inhibitory factor (MIF).- B4: Pathogenesis: iv.
Epidermal mesenchyme transition (EMT).- B5: Pathogenesis: v. ABO blood type.- B6:
Pathogenesis: vi. First relatives of gastric cancer.- C: H. pylori-negative
gastric cancer.- 6) Gastroesophageal reflux disease (GERD).- 7) NSAID-induced
gastropathy and H. pylori infection.- 8) Extraintestinal manifestations of H.
pylori infection.- A: Iron deficiency anemia.- B: Idiopathic thrombocytopenic
purpura.- C: Heart disease.- D: Atopy and allergy.- Part 6. Antibiotic
resistance.- 1) Synopsis of antibiotic resistance.- 2) Clarithromycin.- 3)
Amoxicillin.- 4) Quinolone.- 5) Metronidazole.- Part 7. Treatment.- 1) Synopsis
of antibiotic treatment.- 2) Triple therapy.- 3) Quadruple therapy.- 4)
Sequential therapy.- 5) Concomitant therapy.- 6) Tailored therapy based on
antibiotic resistance.- 7) Levofloxacin or rifabutin based triple therapy.- 8)
Probiotics.- 9) Treatment guidelines.- 10) Screening method of early gastric
cancer.- 11) Recrudescence and reinfection.- Part 8. Consequences of H.
pylori eradication.- 1) Peptic ulcer disease.- 2) atrophic gastritis and
Intestinal metaplasia.- 3) Gastric cancer.- Part 9. The effect of H. pylori on
the other microbiota of stomach.- The effect of H. pylori on the other
microbiota of stomach.- Part 10. Animal model- H. pylori, H. felis.

Erscheint lt. Verlag 27.10.2016
Zusatzinfo 103 Illustrations, color; 11 Illustrations, black and white; X, 556 p. 114 illus., 103 illus. in color.
Verlagsort Singapore
Sprache englisch
Maße 178 x 254 mm
Themenwelt Medizinische Fachgebiete Chirurgie Viszeralchirurgie
Medizinische Fachgebiete Innere Medizin Gastroenterologie
Medizin / Pharmazie Medizinische Fachgebiete Mikrobiologie / Infektologie / Reisemedizin
Medizin / Pharmazie Studium
Naturwissenschaften Biologie Mikrobiologie / Immunologie
Schlagworte antibiotic resistance • Gastroduodenal disease • Helicobacter pylori (H. pylori) • H. pylori Colonization • H. pylori Eradication • Infection • Treatment methods
ISBN-10 981-287-705-3 / 9812877053
ISBN-13 978-981-287-705-5 / 9789812877055
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Wunden versorgen, behandeln, heilen

von Harald Daum; Werner Sellmer; Anke Bültemann

Buch | Softcover (2023)
MWV Medizinisch Wissenschaftliche Verlagsgesellschaft
CHF 55,90